Indivior (LON:INDV) Shares Down 17% – Here’s What Happened

Indivior PLC (LON:INDV)’s stock price traded down 17% on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 720.60 ($9.10). 2,904,792 shares were traded during trading, an increase of 294% from the average session volume of 737,710 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($22.74) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The firm has a market capitalization of £1.08 billion, a price-to-earnings ratio of -570.87, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The business has a fifty day moving average price of GBX 920.11 and a two-hundred day moving average price of GBX 850.81.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.